NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
22 hedge funds and large institutions have $16M invested in NeuBase Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
+6
Holders Change %
+37.5%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
5
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EI
1
EAM Investors
Solana Beach,
California
|
$719K |
| 2 |
2
Renaissance Technologies
New York
|
$2.54M |
| 3 |
3
BlackRock
New York
|
$375K |
| 4 |
4
Millennium Management
New York
|
$206K |
| 5 |
5
JPMorgan Chase & Co
New York
|
$99K |
